SHOX2 and lung carcinoma: It is worth noting that there is little research on the potential prognostic influence and molecular mechanism of SHOX2 in lung cancer, especially in non-small-cell lung cancer (NSCLC) [mainly lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC)].